Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 69097-840

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 69097-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Albuterol Sulfate (Structurealbuterol)

Chemical structure diagram showing the molecular composition of Ipratropium Bromide represented as a sulfate salt. The structure includes a phenyl ring bonded to hydroxyl groups and an amine group with a tert-butyl substituent, indicating the specific arrangement of atoms in the compound.*

FDA Label Image

Iprabr (Structureipra)

Chemical structure diagram of Ipratropium Bromide, showing its molecular configuration including the positive quaternary nitrogen, ester linkage, and bromide hydrate moiety as indicated.*

FDA Label Image

Graph3 (Figure3)

A line graph depicting lung function in liters over 8 hours after dosing with Albuterol, Ipratropium, and Ipratropium Bromide and Albuterol Sulfate combined. The curves compare respiratory volume changes post-inhalation of each treatment over time.*

FDA Label Image

Image 1 (Figure1)

An instructional illustration showing a hand attaching a nasal spray device to a container and a dropper dispensing liquid into the container. This image likely demonstrates preparation or assembly steps for a respiratory inhalation solution device.*

FDA Label Image

Image 2 (Figure2)

An instructional line drawing labeled as Figure 2 showing the attachment of a mouthpiece to a respiratory inhalation device. The diagram highlights the connection process for a solution inhaler, relevant to Ipratropium Bromide and Albuterol Sulfate respiratory administration.*

FDA Label Image

Image 3 And 4 (Figure3and4)

Instructional illustrations showing correct use of a respiratory inhalation solution device. Figure 3 depicts a person inhaling the medication mouthpiece, while Figure 4 shows the device delivering mist into a face mask covering the user's nose and mouth.*

FDA Label Image

Image (Carton)

Packaging label for Ipratropium Bromide and Albuterol Sulfate inhalation solution, showing a solution dosage form for respiratory inhalation. The label highlights the strength as 0.5 mg/3 mL and 2.5 mg/3 mL, intended for oral inhalation use only. The labeler is Cipla USA Inc. The layout includes barcodes, usage instructions, and NDC 69097-840 prominently displayed.*

FDA Label Image

60s (Carton1)

Packaging label for Ipratropium Bromide and Albuterol Sulfate inhalation solution, strength 0.5 mg and 2.5 mg per 3 mL, indicated for oral inhalation only. The label displays the Cipla USA Inc. branding and includes detailed product and usage information. The label is presented as a folding carton layout for the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.